Cell therapy

The following session will cover cell therapy, focusing on the fundamental principles of cell therapy, including its use of living cells to treat diverse diseases, and the distinction between autologous and allergenic approaches. We will discuss cutting edge treatments such as CR T cell and IPSC based therapies, highlighting their mechanisms and clinical impact. The lecture will also address current applications in oncology and regenerative medicine, as well as key challenges related to safety, manufacturing, and regulatory oversight. Finally, we will explore emerging technologies that may further advance the field and expand therapeutic possibilities. Cell therapy is a medical field that uses living cells to treat, repair or replace damaged tissues and organs or to correct disease processes. Its core principle is to harness and transplant cells, either from the patient or a donor for beneficial effects such as tissue regeneration, immune modulation, or disease targeting. Therapies range from bone marrow transplants to newer options like mesenchymal stem cell and cart cell therapies. The source and processing of cells critically affect clinical activity and safety. Cell therapies are often classified as autologous or allergenic. Autologous cell therapy uses the patient's own cells, which are harvested, sometimes modified or expanded, and then reintroduced, ensuring compatibility and minimizing immune rejection, though the process is complex and individualized.